Search Within

Helen Hyeong-Eun Won

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (51)
  2. Journal Article (50)
  3. Research Letter (1)
Groups
  1. GSK Faculty (102)
  2. Human Oncology and Pathogenesis Program (102)
  3. Department of Pathology and Laboratory Medicine (98)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (96)
  5. Department of Medicine (75)
  6. Solid Tumor Oncology Division (72)

More Groups

People
  1. Michael Berger (94)
  2. David Solit (30)
  3. Marc Ladanyi (27)
  4. David Hyman (18)
  5. Hikmat Al-Ahmadie (18)
  6. Maurizio Scaltriti (18)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (7)
  4. 2020 (4)
  5. 2019 (8)
  6. 2018 (7)

More Years

Publications
  1. Modern Pathology (14)
  2. Cancer Research (12)
  3. Laboratory Investigation (11)
  4. Journal of Thoracic Oncology (8)
  5. Clinical Cancer Research (6)
  6. Journal of Clinical Oncology (6)

More Publications

Publishers
  1. Nature Publishing Group (24)
  2. American Association for Cancer Research (23)
  3. Nature Research (15)
  4. Elsevier Inc. (11)
  5. American Society of Clinical Oncology (7)
  6. Oxford University Press (5)

More Publishers

Results (102)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exploring mutational profiles in two major histologic subtypes of ampullary carcinoma by targeted cancer gene sequencing
    Meeting Abstract

    Liu, W.; Shia, J.; Won, H.; Berger, M.; Klimstra, D.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • mTOR pathway activation characterizes a subset of unclassified renal cell carcinoma: Immunohistochemical, molecular and histologic analysis
    Meeting Abstract

    Kong, M. X.; Brannon, A. R. R.; Won, H.; Gandhi, A.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Russo, P.; Berger, M. F.; Tickoo, S. K.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Targeted sequencing analysis of triple negative breast cancer and correlation with clinicopathologic features
    Meeting Abstract

    Jakate, K.; Brogi, E.; Won, H.; Akram, M.; Berger, M.; Wen, Y. H.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Genomic characterization of adrenal cortical neoplasms (carcinoma, borderline tumor and adenoma) by targeted next generation sequencing: A mutational and copy number analysis
    Meeting Abstract

    Gopalan, A.; Won, H.; Nanjangud, G.; Gandhi, A.; Chen, Y. B.; Al-Ahmadie, H. A.; Fine, S. W.; Berger, M. F.; Tickoo, S. K.; Reuter, V. E.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Genomic characterization of adrenal cortical neoplasms (carcinoma, borderline tumor and adenoma) by targeted next generation sequencing: A mutational and copy number analysis
    Meeting Abstract

    Gopalan, A.; Won, H.; Nanjangud, G.; Gandhi, A.; Chen, Y. B.; Al-Ahmadie, H. A.; Fine, S. W.; Berger, M. F.; Tickoo, S. K.; Reuter, V. E.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: The utility of detecting aberrant succination by immunohistochemistry
    Meeting Abstract

    Chen, Y. B.; Brannon, A. R.; Dudas, M. E.; Won, H.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Frizzell, N.; Russo, P.; Berger, M. F.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: The role of massively parallel sequencing
    Journal Article

    De Mattos-Arruda, L.; Bidard, F. C.; Won, H. H.; Cortes, J.; Ng, C. K. Y.; Peg, V.; Nuciforo, P.; Jungbluth, A. A.; Weigelt, B.; Berger, M. F.; more...
    Molecular Oncology (2014)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K pathway-driven stage IV squamous cell lung cancers (SQCLC)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Won, H. H.; Hasanovic, A.; Rekhtman, N.; Sima, C. S.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Longitudinal massively parallel sequencing analysis of circulating cell-free tumor DNA: A feasibility study
    Meeting Abstract

    De Mattos-Arruda, L.; Cortes, J.; Saura, C.; Nuciforo, P.; Bidard, F. C.; Won, H. H.; Weigelt, B.; Berger, M.; Seoane, J.; Reis, J. S.
    Cancer Research (2013)

    Fulltext@MSK | Save